Treating Lithium-Induced Nephrogenic Diabetes Insipidus With a COX-2 Inhibitor Improves Polyuria via Upregulation of AQP2 and NKCC2

American Journal of Physiology - Renal Physiology - United States
doi 10.1152/ajprenal.00366.2007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

4-Pba Improves Lithium-Induced Nephrogenic Diabetes Insipidus by Attenuating ER Stress

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2016English

Use of Amiloride in Lithium-Induced Nephrogenic Diabetes Insipidus

Journal of Analytical & Pharmaceutical Research
2018English

Use of Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus: A Case Report

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Prasugrel Suppresses Development of Lithium-Induced Nephrogenic Diabetes Insipidus in Mice

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2017English

Tamoxifen Attenuates Development of Lithium-Induced Nephrogenic Diabetes Insipidus in Rats

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2018English

Lithium-Induced Diabetes Insipidus.

BMJ
1972English

Development of Lithium-Induced Nephrogenic Diabetes Insipidus Is Dissociated From Adenylyl Cyclase Activity

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Atorvastatin in the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: The Protocol of a Randomized Controlled Trial

BMC Psychiatry
PsychiatryMental Health
2018English

Physiopathology and Diagnosis of Nephrogenic Diabetes Insipidus

Annales d'Endocrinologie
MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy